Evidence map›Paper›PMID 31077266›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Influenza Coinfection: Be(a)ware of Invasive Aspergillosis.

Paul E Verweij, Roger J M Brüggemann, Joost Wauters, Bart J A Rijnders, Tom Chiller, Frank L van de Veerdonk

Abstract readLetterComment
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. The Transcriptome Response to Azole Compounds inJournal of fungi (Basel, Switzerland) · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Outcomes among critically ill adults with influenza infection.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021
    Article
  9. Article
  10. Updated EUCAST Clinical Breakpoints againstJournal of fungi (Basel, Switzerland) · 2020
    Review
  11. Article
  12. InvasiveAmerican journal of respiratory and critical care medicine · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Reply to Verweij et al.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  18. Interactions betweenJournal of fungi (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Paul E VerweijDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Roger J M BrüggemannCenter of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands.
Joost WautersMedical Intensive Care Unit, University Hospitals Leuven, Belgium.
Bart J A RijndersDepartment of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
Tom ChillerMycotic Branch, Centers of Disease Control and Prevention, Atlanta, Georgia.
Frank L van de VeerdonkCenter of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AspergillosisChemopreventionDisease OutbreaksHumansInfluenza, HumanSeasons

Identifiers

PMID31077266
PMCPMC6938972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.